MR Imaging of Hepatic Metastases
2003; Wiley; Volume: 7; Issue: 1 Linguagem: Inglês
10.1046/j.1617-0830.2003.70203.x
ISSN1617-0830
AutoresG. Simón, Heike E. Daldrup‐Link, Ernst J. Rummeny,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoImaging Decisions MRIVolume 7, Issue 1 p. 19-28 MR Imaging of Hepatic Metastases G. H. Simon, Corresponding Author G. H. Simon Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanyGerhard H. Simon, MD Department of Diagnostic Radiology, Technische Universitaet Muenchen Ismaninger Str. 22, D-81675 Munich, Germany Tel: +49 89 41402621; Fax: +49 251 41402616; E-mail: [email protected]Search for more papers by this authorH. E. Daldrup-Link, H. E. Daldrup-Link Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanySearch for more papers by this authorE. J. Rummeny, E. J. Rummeny Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanySearch for more papers by this author G. H. Simon, Corresponding Author G. H. Simon Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanyGerhard H. Simon, MD Department of Diagnostic Radiology, Technische Universitaet Muenchen Ismaninger Str. 22, D-81675 Munich, Germany Tel: +49 89 41402621; Fax: +49 251 41402616; E-mail: [email protected]Search for more papers by this authorH. E. Daldrup-Link, H. E. Daldrup-Link Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanySearch for more papers by this authorE. J. Rummeny, E. J. Rummeny Department of Diagnostic Radiology, Technische Universitaet Muenchen, Munich, GermanySearch for more papers by this author First published: 23 April 2003 https://doi.org/10.1046/j.1617-0830.2003.70203.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 1996; 6(2): 291–294. 10.1002/jmri.1880060206 CASPubMedWeb of Science®Google Scholar 2 Wittenberg J, Stark DD, Forman BH, Hahn PF, Saini S, Weissleder R, Rummeny E, Ferrucci JT. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol 1988; 151(1): 79–84. 10.2214/ajr.151.1.79 CASPubMedWeb of Science®Google Scholar 3 Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991; 180(2): 327–332. 10.1148/radiology.180.2.2068294 CASPubMedWeb of Science®Google Scholar 4 Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001; 218(1): 27–38. 10.1148/radiology.218.1.r01ja2427 CASPubMedWeb of Science®Google Scholar 5 Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190(1): 49–52. 10.1148/radiology.190.1.8259426 CASPubMedWeb of Science®Google Scholar 6 Saini S, Sharma R, Baron RL, Turner DA, Ros PR, Hahn PF, Small WC, Delange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol 2000; 55(9): 690–695. 10.1053/crad.2000.0504 CASPubMedWeb of Science®Google Scholar 7 Rummeny E, Ehrenheim C, Gehl HB, Hamm B, Laniado M, Lodemann KP, Schmiedel E, Steudel A, Vogl TG. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Invest Radiol 1991; 26(Suppl 1): S142–S145. 10.1097/00004424-199111001-00048 PubMedWeb of Science®Google Scholar 8 Mathieu D, Coffin C, Kobeiter H, Caseiro-Alves F, Mahfouz A, Rahmouni A, Diche T. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir. J Magn Reson Imaging 1999; 10(2): 193–195. 10.1002/(SICI)1522-2586(199908)10:2 3.0.CO;2-2 CASPubMedWeb of Science®Google Scholar 9 Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 1994; 20(!!4 Pt 1): 917–923. 10.1002/hep.1840200421 CASPubMedWeb of Science®Google Scholar 10 Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212(3): 876–884. 10.1148/radiology.212.3.r99se34876 CASPubMedWeb of Science®Google Scholar 11 Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196: 481–488. 10.1148/radiology.196.2.7617864 CASPubMedWeb of Science®Google Scholar 12 Nakayama M, Yamashita Y, Mitsuzaki K, Yi T, Arakawa A, Katahira K, Nakayama Y, Takahashi M. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging 2000; 11(6): 647–654. 10.1002/1522-2586(200006)11:6 3.0.CO;2-F CASPubMedWeb of Science®Google Scholar 13 Bluemke DA, Paulson EK, Choti MA, DeSena S, Clavien PA. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. AJR Am J Roentgenol 2000; 175: 1653–1658. 10.2214/ajr.175.6.1751653 CASPubMedWeb of Science®Google Scholar 14 Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 1998; 7(2): 76–87. 10.1007/BF02592232 CASPubMedWeb of Science®Google Scholar 15 Oudkerk M, Van Den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997; 203: 449–456. 10.1148/radiology.203.2.9114103 CASPubMedWeb of Science®Google Scholar 16 Vogl TJ, Hammerstingl R, Schwarz W, Mack MG, Muller PK, Pegios W, Keck H, Eibl-Eibesfeldt A, Hoelzl J, Woessmer B, Bergman C, Felix R. Superparamagnetic iron oxide – enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198: 881–887. 10.1148/radiology.198.3.8628887 CASPubMedWeb of Science®Google Scholar 17 Helmberger T, Gregor M, Holzknecht N, Gauger J, Rau H, Reiser MF. Comparison of dual-phase helical CT with native and ferumoxide-enhanced magnetic resonance imaging in detection and characterization of focal liver lesions. Radiologe 1999; 39(8): 678–684. 10.1007/s001170050565 CASPubMedWeb of Science®Google Scholar 18 Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, Van Persijn van Meerten EE, Bloem JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup HE, Rummeny E, Kirchin MA, Pirovano G, Hamm B. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging – a multicenter phase III clinical study. Radiology 2000; 215: 727–736. 10.1148/radiology.215.3.r00jn14727 CASPubMedWeb of Science®Google Scholar 19 Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol 2000; 175: 1111–1120. 10.2214/ajr.175.4.1751111 CASPubMedWeb of Science®Google Scholar 20 Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212(3): 876–884. 10.1148/radiology.212.3.r99se34876 CASPubMedWeb of Science®Google Scholar 21 Federle M, Chezmar J, Rubin DL, Weinreb J, Freeny P, Schmiedl UP, Brown JJ, Borrello JA, Lee JK, Semelka RC, Mattrey R, Dachman AH, Saini S, Harms SE, Mitchell D, Anderson MW, Halford HH 3rd, Bennett WF, Young SW, Rifkin M, Gay SB, Ballerini R, Sherwin PF, Robison RO. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials. Efficacy of early imaging. J Magn Reson Imaging 2000; 12(5): 689–701. 10.1002/1522-2586(200011)12:5 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 22 Frate CD, Bazzocchi M, Mortele KJ, Zuiani C, Londero V, Como G, Zanardi R, Ros PR. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 2002; 225: 766–772. 10.1148/radiol.2253011854 PubMedWeb of Science®Google Scholar 23 Van Erkel AR, Pijl MEJ, Van Den Berg-Huysmans AA, Wasser MNJM, Van De Velde CJH, Bloem JL. Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology 2002; 224: 404–409. 10.1148/radiol.2242011322 PubMedWeb of Science®Google Scholar 24 Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP, Pringot J, Mathieu D, Bruel JM. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785–792. 10.1148/radiology.200.3.8756932 CASPubMedWeb of Science®Google Scholar 25 Soyer P, Bluemke DA, Fishman EK. CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when, and why? AJR Am J Roentgenol 1994; 163: 1325–1331. 10.2214/ajr.163.6.7992722 CASPubMedWeb of Science®Google Scholar 26 Bluemke DA, Paulson EK, Choti MA, DeSena S, Clavien PA. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. AJR Am J Roentgenol 2000; 175: 1653–1658. 10.2214/ajr.175.6.1751653 CASPubMedWeb of Science®Google Scholar 27 Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis. Radiology 2002; 224: 748–756. 10.1148/radiol.2243011362 PubMedWeb of Science®Google Scholar Citing Literature Volume7, Issue1April 2003Pages 19-28 ReferencesRelatedInformation
Referência(s)